Weinberg et al., J. Immunol., vol. 150, p. 103A, 1993.* |
Schwarting et al., Section A7.1, from: “Leucocyte Typing IV White Cell Differentiation Antigens”, Ed. W. Knapp et al., Oxford Univ. Press, 1992, pp. 464, 465.* |
Aversa et al., Section A 8.15, from: “Leucocyte Typing IV White Cell Differentiation Antigens”, Ed. W. Knapp et al., Oxford Univ. Press, 1992, pp. 498-501.* |
Osband et al., Imm. Today, 11: 103-105, 1990.* |
Miura et al., “Molecular Cloning and Characterization of a Novel Glycoprotein, gp34, That Is Specifically Induced by the Human T-Cell Leukemia Virus Type I Transactivator p40tax,” Mol. Cell. Biol. 11:1313-1325 (1991). |
W. Godfrey et al., ‘Molecular Cloning of a cDNA encoding the human homolog of the rat OX-40 antigen’, p. 253, Tissue Antigens, vol. 42, No. 4, Oct. 1993, Copenhagen, Denmark. |
S. Hamilton-Dutoit et al., ‘An immunohistological analysis of the mAb in the activation antigen panel’, p. 475-p. 476, ‘Leucocyte Typing IV. White Cell Differentiation Antigens (Eds. W. Knapp et al.)’ 1989, Oxford University Press, Oxford, GB. |
J. Waugh et al., ‘Staining of normal or rejecting kidney using the activation panel’, p. 485-p. 486, ‘Leucocyte Typing IV. White Cell Differentiation Antigens (Eds. W. Knapp et al.)’ 1989, Oxford University Press, Oxford, GB. |
N. Dunlap et al., ‘Expression of activation antigens on HTLV-I and HTLV-II cell lines’, p. 487-p. 488, ‘Leucocyte Typing IV. White Cell Differentiation Antigens (Eds. W. Knapp et al.)’ 1989, Oxford University Press, Oxford, GB. |
R. Vilella et al., ‘Sequential appearance of the activation antigens’, p. 495-p. 498, ‘Leucocyte Typing IV. White Cell Differentiation Antigens (Eds. W. Knapp et al.)’ 1989, Oxford University Press, Oxford, GB. |
G. Aversa et al., ‘Activation panel antigen expression on PBL activated by PHA or in MLR’, p. 498-p. 501, ‘Leucocyte Typing IV. White Cell Differentiation Antigens (Eds. W. Knapp et al.)’ 1989, Oxford University Press, Oxford, GB. |
P. King et al., ‘Tonsillar dendritic-cell-induced T-lymphocyte proliferation: analysis of molecular mechanisms using the activation panel of mAb’, p. 503-p. 505, ‘Leucocyte Typing IV. White Cell Differentiation Antigens (Eds. W. Knapp et al.)’ 1989, Oxford University Press, Oxford, GB. |
O. Rentrop et al., ‘Biochemical analysis of the workshop antibodies of the activation section’, p. 473-p. 474, ‘Leucocyte Typing IV. White Cell Differentiation Antigens (Eds. W. Knapp et al.)’ 1989, Oxford University Press, Oxford, GB. |
U. Latza et al., ‘The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen’, pp. 677-683, European Journal of Immunology, vol. 24, No. 3, Mar. 1994, Weinheim, Germany. |
W. Godfrey et al. ‘Identification of a human OX-40 ligand, a a costimulator of CD4+ T cells with homology to tumor necrosis factor’, pp. 757-762, The Journal of Experimental Medicine, vol. 180, No. 2, Aug. 1994, New York NY, USA. |
W. Godfrey et al., ‘Stan-40, a new member of the FAS-TNFr superfamily expressed selectively on activated, human CD+ T cells’, p. 355, Journal of Cellular Biochemistry, Supplement, vol. 0, No. 18D, 1994, New York NY, USA. |
Calderhead et al., “Cloning of Mouse OX40: A T Cell Activation Marker That May Mediate T-B Cell Interactions,” J. Immun. 151:5261-5271 (1993). |
Holoshitz et al., “Arthritis Induced in Rats by Cloned T Lymphocytes Responsive to Mycobacteria but Not To Collagen Type II,” J. Clin. Invest. 73:211-215 (1984). |
Kennedy et al., “Analysis of Cytokine mRNA Expression in the Central Nervous System of Mice with Experimental Autoimmune Encephalomyelitis Reveals that IL-10 mRNA Expression Correlates with Recovery,” J. Immun. 149:2496-2505 (1992). |
Khoury et al., “Oral Tolerance to Myelin Basic Protein and Natural Recovery from Experimental Autoimmune Encephalomyelitis Are Associated with Downregulation of Inflammatory Cytokines and Differential Upregulation of Transforming Growth Factor β, Interleukin 4, and Prostaglandin E. Expression in the Brain,” J. Exp. Med. 176:1355-1364 (1992). |
Mallett et al., “Characterization of the MRC OX40 Antigen of Activated CD4 Positive T Lymphocytes—a Molecule Related to Nerve Growth Factor Receptor,” EMBO J. 9:1062-1068 (1990). |
Paterson et al., “Antigens of Activated Rat T Lymphocytes Including a Molecule of 50,000Mr Detected Only on CD4 Positive T Blasts,” Mol. Immun. 24:1281-1290 (1987). |
Steinman Lawrence, “Autoimmune Disease,” Sci. Amer. 9:107-114 (1993). |
Vitetta et al., “Phase I Immunotoxin Trial in Patients with B-Cell Lymphoma,” Cancer Res. 51:4052-4058 (1991). |
Weinberg et al., “Transforming Growth Factor-β Enhances the in Vivo Effector Function and Memory Phenotype of Antigen-Specific T Helper Cells in Experimental Autoimmune Encephalomyelitis,” J. Immun. 148:2109-2117 (1992). |
Queen et al., “A Humanized Antibody that Binds to the Interleukin 2 Receptor,” Proc. Natl. Acad. Sci. 86:10029-10033 (1989). |
Lohse and Cohen, “Immunoregulation: Studies of Physiological and Therapeutic Autoreactivity by T Cell Vaccination,” Springer Semin. Immunopathol. 14:179-186 (1992). |
Chatterjee et al., “Idiotypic Antibody Immunotherapy of Cancer,” Cancer Immunol. Immunother. 38:75-82 (1994). |
Harris et al., “Therapeutic Antibodies—The Coming of Age,” TibTech 11:42-44 (1993). |
Emery and Adair, “Humanized Monoclonal Antibodies for Therapeutic Applications,” Exp. Opin. Invest. Drugs 3:241-251 (1994). |
Winter and Harris, “Antibody-Based Therapy, Humanized Antibodies,” TIPS 14:139-143 (1993). |
Kahan, “Immunosuppressive Therapy,” Cur. Opin. Immunol. 4:553-560 (1992). |
Borrebaeck et al., “Does Endogenous Glycosylation Prevent the Use of Mouse Monoclonal Antibodies as Cancer Therapeutics?,” Immunol. Today 14:477-482 (1993). |
Waldmann, “Monoclonal Antibodies in Diagnosis and Therapy,” Science 252:1657-1662 (1991). |
Parker et al., “Fusion Proteins in Immunotherapy,” Trans. Proc. 24:2362-2365 (1992). |
Baum et al., Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34, The EMBO Journal, 13(17):3992-4001 (1994). |
Mallett et al., A new superfamily of cell surface proteins related to the nerve growth factor receptor, Immunology Today 12(7):220-223 (1991). |
Weinberg et al., Target organ-specific up-regulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encepahalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis, J. Immunol., 152(9):4712-21 (1994). |